Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 March 2023 | Story Kekeletso Takang and Lacea Loader | Photo UFS Photo Archive
Tate_Makgoe
Tate Makgoe, late MEC of Education in the Free State.

The management of the University of the Free State (UFS) is shocked and saddened to learn of the untimely passing of Tate Makgoe, member of the Executive Council (MEC) for Education in the Free State, who passed away on Sunday 5 March 2023 after a car accident.

MEC Makgoe was a UFS Council member as representative of the Free State Premier for two terms, from 1 November 2010 to 31 December 2018. He was also a member of the Executive Committee of Council in his second term.

“On behalf of the UFS Council, the university management, and the university community, I would like to express our heartfelt condolences to MEC Makgoe’s family, Premier Mxolisi Dukwana, and the Executive Council of the Free State, as well as the Free State education sector at large, for the loss of a great leader,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor.  

MEC Makgoe had a strong relationship with the UFS, which saw him collaborating on numerous projects, including the Internet Broadcast Project from 2012 to 2022, which was aimed at supporting Grade 12 learners and teachers.

Prof Petersen acknowledged MEC Makgoe for his contributions to the university, the institution’s Council, and the province’s education sector. “We are proud to have been associated with MEC Makgoe. Not only in his capacity as MEC, but also as alumnus. He held an Honours degree in Commerce from the UFS and was registered for a PhD in Education Leadership and Policy Studies at the university at the time of his passing. In 2013, he received a Cum Laude Award during the Chancellor's Distinguished Alumni Awards ceremony,” said Prof Petersen.

Through continued collaboration and under his leadership, the Free State reclaimed its top spot in the National Senior Certificate examination results in 2019 and has maintained it to date. “This would not have been possible without the leadership of MEC Makgoe; we salute him for the significant role he played, and for his contribution to the success of the province over the past few years,” said Prof Petersen.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept